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Abstract
Neonatal noxious insult produces a long-term effect on pain processing in adults. Rats subjected to
carrageenan (CAR) injection in one hindpaw within the sensitive period develop bilateral
hypoalgesia as adults. In the same rats, inflammation of the hindpaw, which was the site of the
neonatal injury, induces a localized enhanced hyperalgesia limited to this paw. To gain an insight
into the long-term molecular changes involved in the above-described long-term nociceptive effects
of neonatal noxious insult at the spinal level, we performed DNA microarray analysis (using
microarrays containing oligo-probes for 205 genes encoding receptors and transporters for
glutamate, GABA, and amine neurotransmitters, precursors and receptors for neuropeptides, and
neurotrophins, cytokines and their receptors) to compare gene expression profiles in the lumbar
spinal dorsal horn (LDH) of adult (P60) male rats that received neonatal CAR treatment within (at
postnatal day 3; P3) and outside (at postnatal 12; P12) of the sensitive period. The data were
obtained both without inflammation (at baseline) and during complete Freund's adjuvant induced
inflammation of the neonatally injured paw. The observed changes were verified by real-time RT-
PCR. This study revealed significant basal and inflammation-associated aberrations in the
expression of multiple genes in the LDH of adult animals receiving CAR injection at P3 as compared
to their expression levels in the LDH of animals receiving either no injections or CAR injection at
P12. In particular, at baseline, twelve genes (representing GABA, serotonin, adenosine,
neuropeptide Y, cholecystokinin, opioid, tachykinin and interleukin systems) were up-regulated in
the bilateral LDH of the former animals. The baseline condition in these animals was also
characterized by up-regulation of seven genes (encoding members of GABA, cholecystokinin,
histamine, serotonin, and neurotensin systems) in the LDH ipsilateral to the neonatally-injured paw.
The largest aberration in gene expression, however, was observed during inflammation of the
neonatally injured hindpaws in the ipsilateral LDH, which included thirty-six genes (encoding
numerous members of glutamate, serotonin, GABA, calcitonin gene-related peptide, neurotrophin,
and interleukin systems). These findings suggest that changes in gene expression may be involved
in the long-term nociceptive effects of neonatal noxious insult at the spinal level.
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Introduction
Emerging evidence indicates that neonatal noxious insults
result in changes in pain responsivity in adults (reviewed
in: [1-3]). It has been demonstrated that these changes
may, at least in part, be associated with permanent altera-
tions in pain processing in the spinal cord [4-7].
Recently, we have developed a carrageenan (CAR) injec-
tion-based rat model of short-lasting (24 – 48 h) locally-
induced noxious insult. In this model, rats subjected to a
single subcutaneous injection of CAR into a hindpaw after
birth, develop a long-term widespread bilateral increase in
baseline nociceptive threshold along with a long-term
enhanced localized ipsilateral increase in nocifensive
responses (enhanced hyperalgesia) to adult inflammation
of the neonatally-injured paw [8,9]. We also determined
that the sensitive period for generating these effects is
within the first postnatal week [9]. The present study was
aimed at screening for changes in gene expression, which
may be involved in the above-described long-term nocic-
eptive effects of neonatal noxious insult at the spinal level.
Here, we largely focused on three aspects of gene expres-
sion in the lumbar region of the spinal dorsal horn (LDH)
of adult rats receiving CAR injection during the neonatal
sensitive period. First, in expectation of gaining insight
into the spinal contribution to the bilateral baseline
hypoalgesia characteristic of our model, we identified
changes in gene expression encompassing LDH on both
ipsilateral and contralateral sides to the neonatally injured
hindpaw. Second, we identified baseline changes in gene
expression unique to the LDH ipsilateral to the site of neo-
natal injury. The interest in the latter changes was
prompted by findings in several studies [4,5,7] that the
apparent similarity in the latency of withdrawal responses
to acute noxious stimulation in both hindpaws of adult
animals, which received neonatal injections of inflamma-
tory agents, occurs in the presence of long-term alterations
in the receptive field sizes, background activity, and
evoked responses of the LDH neurons receiving informa-
tion from the neonatally-injured paw. Therefore, we
hoped that our observations might aid in explaining why
these diverse structural/physiological changes do not
result in locally-altered behavioral pain responsivity.
Third, we investigated abnormalities in gene regulation,
which may be associated with hyperalgesia seen in our
model upon adult inflammation of the neonatally-
injured paw.
To achieve our goal we employed microarray profiling of
gene expression in the ipsilateral and contralateral LDH of
adult rats receiving neonatal CAR hindpaw injections
either within or outside of the sensitive period, both at
baseline and during complete Freund's adjuvant (CFA)-
induced inflammation of neonatally CAR-injected paws.
The analysis employed custom-designed glass microarrays
containing 205 sixty-mer oligo-probes for all known
genes for: glutamate, gamma-aminobutyric acid (GABA),
adrenaline and serotonin transporters; glutamic acid
decarboxylase (GAD); N-methyl-D-aspartate (NMDA),
alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic
acid (AMPA), kainate, GABAA receptor subunits, gluta-
mate metabotropic, GABAB, adenosine, adrenergic, sero-
tonergic, histamine, and σ receptors; and peptide
precursors and receptors for opioids, somatostatin
(SOM), neuropeptide Y (NPY), tachykinins, neurotensin,
calcitonin gene-related peptide (CGRP), cholecystokinin
(CCK), and vasoactive intestinal peptide (VIP). Probes for
a range of neurotrophins and cytokines and their recep-
tors were also included. Each microarray-identified
change in gene expression was verified by quantitative
real-time reverse transcription-polymerase chain reactions
(real-time RT-PCRs).
Results
Microarray-based Gene Expression Profiling
In assessing the microarray-generated data, we began by
looking at the results of comparison of gene expressions
in the adult (60-days-old; P60) male rats receiving a single
CAR injection within the sensitive period (on P3 [9]; CAR-
P3 group) and rats receiving CAR injection outside the
sensitive period (on P12 [9]; CAR-P12 group) with those
in the animals receiving no such injections (CONT
group). Then, we turned to comparison of gene expres-
sions between CAR-P3 and CAR-P12 rats to identify
changes that may be specifically related to the CAR injec-
tion at P3. The latter comparison was aimed at discarding
changes that might be common to both CAR treatments
within and outside of the sensitive period.
Baseline Levels of Gene Expression
The search for bilateral effects identified seven genes (cod-
ing for GABAB1d receptor, 5-HT5a serotonergic receptor,
A1 adenosine receptor, σ receptor, NPYR6 receptor, pre-
proenkephalin, and γ-tachykinin) with significantly
increased expression in the ipsilateral and contralateral
LDH of CAR-P3 rats as compared to those in CONT ani-
mals (Table 1). These increases ranged from 1.5 to 3.5
fold. No significant alterations in the expression of these
genes were detected in the CAR-P12 group (Table 1),
which made the observed changes specific for CAR-P3
animals. Six more genes (coding for GAD65, α2b and β3
adrenergic receptors, δ-preprotachykinin, CCKR-1 recep-
tor, and interleukin IL-10) showed higher bilateral levels
of gene expression in both CAR-3 and CAR-P12 groups
(Table 1). However, in CAR-P3 rats these genes were
expressed at significantly higher levels (by 1.2 – 2.6 fold)
than in CAR-P12 animals (Table 1). Finally, two genes
(NR2B subunit of NMDA receptor and SstR2 somatostatin
receptor), while being up-regulated in both CAR-P3 and
CAR-P12 groups relative to CONT group, showedMolecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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significantly lower levels of expression (by 0.5 and 0.7
fold respectively) in CAR-P3 rats as compared to those in
CAR-P12 animals (Table 1).
In addition to bilateral changes, comparison of the CONT
and CAR-P3 groups revealed neonatal CAR injection-
induced up-regulation (by 1.9–3.2 fold) of seven genes
(coding for GABAB1f, GABAB1b, 5-HT1b serotonergic,
NtsR1 neurotensin and H1 histamine receptors, GAG67,
and preprocholecystokinin) confined to the left LDH ipsi-
lateral to the neonatal injury (Table 2). These changes
were undetectable in CAR-P12 rats, indicating their CAR-
P3 specificity.
Adult inflammation-induced Changes in Gene Expression in the LDH 
Ipsilateral to the Neonatally-injured Hindpaw
In the left LDH ipsilateral to the site of neonatal injury in
CAR-P3 rats, twenty-six genes showed side-selective adult
inflammation-induced up-regulation (ranging from 1.4
to 6.1 fold) compared to their expressions in the corre-
sponding LDH of CONT animals with similarly inflamed
left hindpaw (Table 3). These included genes coding for:
NR1-4a and NR3B subunits of NMDA receptor, GluRD
and GluR6 subunits of AMPA receptor, GABAAα2 and
GABAAα4, subunits of GABAA receptor, GABAB1b recep-
tor, 5-HT1a, 5-HT1d, 5-HT1e, 5-HT1f, 5-HT2c, 5-HT4, 5-
HT5a, and 5-HT6 serotonergic receptors, calcitonin gene-
related polypeptide-2 (CALK-2), neurotrophin 3 (NT-3),
TrkA and TrkC neurotrophin receptors, IL-1α, IL-6, IL-
12A, IL-15, IL-20, and IL-24 interleukins, and IL-12 β1
interleukin receptor. No significant changes in these genes
were observed in the CAR-P12 group (Table 3), indicating
that the aforementioned alterations in gene expression
were CAR-P3-specific. Additionally, thirteen genes exhib-
ited similarly ipsilateral up-regulations in both CAR-P3
and CAR-P12 rats, but the increases in the CAR-P3 group
were significantly greater (by 1.1 – 2.4 fold) than those in
the CAR-P12 group (Table 3). These genes encode: NR1-
1b, NR2A, and NR2D subunits of NMDA receptor,
mGluR1a metabotropic receptor, GABAAα5 and
GABAAα6, subunits of GABAA receptor, GABAB1c recep-
tor, 5-HT5b serotonergic receptor, calcitonin gene-related
peptide receptor (CGRPR), NT-4 neurotrophin, and IL-5
interleukin. Finally, one gene (encoding NK2 tachykinin
receptor), while also being up-regulated in the CAR-P3
and CAR-12 groups, showed a significantly weaker
increase in CAR-P3 rats as compared to that in CAR-P12
animals (by 0.7 fold).
Among the genes examined in this study, only one
(encoding  σ receptors) showed significant bilateral
changes in its expression in CAR-P3 rats (but not in CAR-
Table 1: Genes with significantly altered basal bilateral levels in the LDH of CAR-P3 as compared to their bilateral expressions in the 
LDH of CONT and CAR-P12 animals [one-way ANOVAs, (with the Benjamini and Hochberg's FDR correction procedure set at the P-
value cutoff of 0.05) followed by Tukey's post-hoc tests (with the same P-cutoff value) in the implementation of GeneSpring GX 
software (Agilent, Palo Alto, CA).)]. Differences in gene expression are presented as ratios between CAR-P3 and CONT, CARP-12 
and CONT, and CAR-P3 and CAR-P12 groups. Statistically insignificant differences are marked as 'ND' The comparisons are based on 
the microarray profiling that employed 5 slides for comparison of CONT and CAR-P3 samples and another 5 slides for comparison of 
CONT and CAR-P12 samples.
Genes Left LDH (ipsilateral to the site of neonatal injury) Right LDH (contralateral to the site of neonatal injury)
CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12 CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12
GABAB1d 1.6 ND 2.1 2.2 ND 2.2
GAD65 2.1 1.8 1.2 2.5 1.4 1.8
A1 aden. rec. 2.2 ND 2.0 1.55 ND 1.64
Pre-proenkephalin 2.0 ND 1.5 1.5 ND 1.9
σ rec. 3.2 ND 2.9 2.3 ND 2.5
NPYR6 3.5 ND 2.7 2.8 ND 2.8
γ-tachikinin 2.1 ND 2.3 2.7 ND 3.1
δ-preporotachykinin 2.2 1.5 1.5 3.1 1.8 1.7
α2b adr. rec. 2.0 1.6 1.2 3.0 1.7 1.8
β3 adr. rec. 2.2 1.7 1.3 3.0 1.7 1.8
5-HT5a 2.0 ND 1.8 1.6 ND 1.2
CCKR-1 2.2 1.8 1.2 3.4 2.3 1.5
IL-10 4.3 1.6 2.6 2.0 1.4 1.4
NR2B 2.2 3.7 0.6 2.4 5.0 0.5
SstR2 2.2 3.2 0.7 3.9 5.3 0.7Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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P12 animals) after adult inflammation of neonatally-
injured hindpaw (left side: CAR-P3/CONT = 3.7 and CAR-
P3/CAR-P12 = 2.6; right side: CAR-P3/CONT = 2.8 and
CAR-P3/CAR-P12 = 1.9).
Verification of the Microarray-identified Alterations in 
Gene Expression by Real-time RT-PCR
The real-time RT-PCR analysis supported the findings of
the microarray gene profiling, with two exceptions (Figs.
1, 2, 3). First, at the baseline, the expressions of the gene
coding for 5-HT5a receptor, although upregulated vs.
CONT rats were similar in CAR-P3 and CAR-P12 animals
on the side ipsilateral to the neonatally-injured paw.
There were also no differences in the expression of this
gene between all three groups on the contralateral side
(Fig. 1). Second, no differential expression of the gene for
NT4 factor was detected between our animal groups after
adult inflammation (Fig. 3). Consequently, these effects
identified by microarrays were judged to be false.
Discussion
This study has revealed that CAR injection of a hindpaw
in rat pups during neonatal sensitive period leads to
abnormal expression levels of multiple genes in the LDH
of adult animals, both at the basal and CFA-induced
inflammation states. All of the affected genes showed up-
regulation, which parallels the earlier observation that
peripheral nerve injury largely causes up-regulation of
genes encoding signal carrying and modulating proteins
in the LDH [10]. Our findings support the notion that reg-
ulatory mechanisms of gene expression in the pain-
processing circuitry of the spinal cord are vulnerable to
long-term alterations by early local noxious insult.
Bilateral Alterations in Gene Expression in the LDH at 
Baseline
Among 205 genes profiled in this study, the expression of
twelve genes were up-regulated in a bilateral fashion in
the LDH of CAR-P3 rats either exclusively or much
stronger than that in CAR-P12 animals. These genes
encode members of several protein groups, such as GABA
synthesis enzymes and receptors, interleukins and their
receptors, serotonin, adenosine, σ, NPY, and CCK recep-
tors, and opioid, and tachykinin peptides; yet, each of
these groups is represented only by one or two genes sug-
gesting that, at least for the examined genes, the observed
changes in expression are diffused, without any group
being perceived as a dominant carrier of these changes.
However, it is interesting that the translational products of
the majority of these genes are most likely to enhance
inhibitory processing of nociceptive input in the LDH.
These include genes encoding GAD65 GABA synthesis
enzyme, anti-inflammatory cytokine, IL-10, and
GABAB1d, A1 adenosine, α2b and β3 adrenergic, and
NPYR6 receptors [11-23]. The remaining genes encode
largely pro-nociceptive products, CCKR-1 and σ-recep-
tors, γ-tachykinin, and δ-preprotachikinin [24-26]. Over-
all, these data are consistent with the previous findings of
bimodal inhibitory and facilitatory changes in descending
spinal modulation of nociception after tissue injury [27].
Nevertheless, this prevalence of bilateral changes in gene
expression promoting anti-nociception points to a possi-
ble net increase in the spinal nociception inhibitory drive,
which would be a contributing factor to the bilateral
hypoalgesia in CAR-P3 rats. An enhanced spinal anti-
nociceptive drive is further supported by our recent micro-
array gene profiling studies in the periaqueductal gray
(PAG), which is a major brain center involved in endog-
enous pain control. These studies showed that the PAG in
CAR-P3 animals is characterized by up-regulation of sev-
Table 2: Genes with significantly altered basal levels in the left LDH ipsilateral to the neonatally-injured hindpaw in CAR-P3 as 
compared to their expressions in the corresponding LDH of CONT and CAR-P12 animals [one-way ANOVAs, (with the Benjamini and 
Hochberg's FDR correction procedure set at the P-value cutoff of 0.05) followed by Tukey's post-hoc tests (with the same P-cutoff 
value) in the implementation of GeneSpring GX software (Agilent, Palo Alto, CA).)]. Differences in gene expression are presented as 
ratios between CAR-P3 and CONT, CAR-P12 and CONT, and CAR-P3 and CAR-P12 groups. Statistically insignificant differences are 
marked as 'ND' The comparisons are based on the microarray profiling that employed 5 slides for comparison of CONT and CAR-P3 
samples and another 5 slides for comparison of CONT and CAR-P12 samples.
Left LDH (ipsilateral to the site of neonatal injury)
Genes CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12 Genes CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12
GABAB1b 1.9 ND 1.7 NtsR1 2.1 ND 1.6
GABAB1f 3.2 ND 2.0 5-HT1b 2.0 ND 1.8
GAD67 2.0 ND 1.4 Preprocholec
ystokinin
2.2 ND 2.0
H1 hist. rec. 3.2 ND 1.7Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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eral genes involved in promoting descending inhibition
in these animals [28].
It should also be noted that not all alterations in gene
expression were stronger in CAR-P3 then in CARP-12 ani-
mals. We found two genes that were up-regulated in CAR-
P3 group less than in CARP-12 group; one (encoding
NR2B subunit of MNDA receptor) is likely pro-nocicep-
tive, while another (encoding SstR2 receptor) is anti-noci-
ceptive [29,30].
Changes in Gene Expression in the LDH Ipsilateral to 
Neonatally-Injured Hindpaw at the Baseline and During 
Adult Inflammation
Without adult inflammation, seven genes showed signifi-
cant CAR-P3-specific up-regulation in their expression in
the LDH ipsilateral to the neonatally-injured hindpaw.
Three of these genes code for anti-nociceptive products
involved in GABA neurotransmission: GAD 67, and
GABAB1b and GABAB1f receptors [12-14], while the other
four genes generate potentially pro-nociceptive products,
preprocholecystokinin, and NtsR1 neurotensin, H1 hista-
mine and 5-HT1b serotonergic receptors [26,31-34].
These findings do not support our expectation of strong
gene-expression driven baseline inhibition of pain
processing in the LDH on the neonatally-injured side.
Clearly, more studies are needed to reconcile long-term
changes induced specifically in the ipsilateral LDH by
neonatal inflammation of a hindpaw with the apparent
similarity in baseline pain responsiveness of both
hindpaws.
Previously, we suggested [9] that specific localized early
noxious insult-induced long-term deficits in the molecu-
lar organization of the spinal circuitry processing nocice-
ptive information from the neonatally-injured hindpaw
are likely to be most notable during a strong local chal-
lenge, such as CFA-induced inflammation of the neona-
tally-injured paw. Indeed, the present study noted that
adult inflammation of the left hindpaw (which had
received CAR injections in CAR-P3 and CAR-P12 animals)
induced significant up-regulation in expression of thirty-
six genes in the ipsilateral LDH of CAR-P3 rats as com-
pared to that in similarly-inflamed CONT animals. These
Table 3: Genes with significant adult inflammation-induced alterations in their expressions in the left LDH (ipsilateral to the CFA-
inflamed neonatally-injured hindpaw) in CAR-P3 rats as compared to those in the left LDH of CONT and CAR-P12 animals after 
inflammation of the corresponding paw [one-way ANOVAs, (with the Benjamini and Hochberg's FDR correction procedure set at the 
P-value cutoff of 0.05) followed by Tukey's post-hoc tests (with the same P-cutoff value) in the implementation of GeneSpring GX 
software (Agilent, Palo Alto, CA).)]. Differences in gene expression are presented as ratios between CAR-P3 and CONT, CAR-P12 
and CONT, and CAR-P3 and CAR-P12 groups. Statistically insignificant differences are marked as 'ND' The comparisons are based on 
the microarray profiling that employed 5 slides for comparison of CONT and CAR-P3 samples and another 5 slides for comparison of 
CONT and CAR-P12 samples.
Left LDH (ipsilateral to the site of neonatal injury)
Genes CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12 Genes CAR-P3/CONT CAR-P12/CONT CAR-P3/CAR-P12
5-HT1a 3.3 ND 2.4 GABAAα2 2.0 ND 2.0
5-HT1d 1.9 ND 2.1 GABAAα4 1.8 ND 2.0
5-HT1e 1.6 ND 1.6 GABAAα5 1.9 1.4 1.4
5-HT1f 1.8 ND 2.0 GABAAα6 2.9 1.7 1.7
5-HT2c 1.4 ND 1.7 GABAB1b 2.6 ND 2.4
5-HT4 1.9 ND 2.4 GABAB1c 2.2 1.5 1.5
5-HT5a 3.0 ND 2.3 NR1-1b 3.2 2.4 1.3
5-HT5b 3.1 2.1 1.5 NR1-4a 2.2 ND 2.0
5-HT6 1.7 ND 1.7 NR2A 2.1 1.5 1.4
IL-1α 1.6 ND 1.6 NR2D 2.3 1.5 1.5
IL-5 2.5 1.6 1.6 NR3B 1.6 ND 2.0
IL-6 1.8 ND 2.2 GluRD 2.0 ND 2.0
IL-12A 1.7 ND 1.3 GluR6 2.1 ND 1.7
IL-12R β1 6.1 ND 4.3 mGluR1a 2.5 1.4 1.8
IL-15 2.4 ND 2.0 CGRPR 2.6 1.5 2.4
IL-20 3.4 ND 2.4 NT-4 2.0 1.2 1.6
IL-24 3.5 ND 3.0 CALK2 2.5 ND 1.9
TrkA 2.3 ND 2.0 VGF 2.6 ND 1.4
TrkC 1.5 ND 1.4 NK2 1.5 2.2 0.7Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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Real-time RT-PCR-determined levels of expression (calculated as R0 using β-actin as internal control) for genes identified by  microarray profiling as having significantly altered basal bilateral levels in the LDH of CAR-P3 as compared to their bilateral  expressions in the LDH of CONT and CAR-P12 animals (Table 1) Figure 1
Real-time RT-PCR-determined levels of expression (calculated as R0 using β-actin as internal control) for genes identified by 
microarray profiling as having significantly altered basal bilateral levels in the LDH of CAR-P3 as compared to their bilateral 
expressions in the LDH of CONT and CAR-P12 animals (Table 1). A, genes, which were identified by microarrays as having 
similar expressions in CONT and CARP-12 groups, but changed (up-regulated) in CAR-P3 group. B, genes, which were identi-
fied by microarrays as having differences in expression between CONT and CAR-P3 and CAR-P12 groups as well as between 
CARP-3 and CAR-P12 groups (both when CAR-P3 > CAR-P12 and CAR-P3 < CAR-P12). The data for the LDH ipsilareal to 
the neonatally-injured paw and the LDH contralateral to that paw are shown separately. Each data-point represents a mean of 
5 animals in a group. The data were analyzed using one-way ANOVAs, (with the Benjamini and Hochberg's FDR correction 
procedure set at the P-value cutoff of 0.05) followed by Tukey's post-hoc tests (with the same P-cutoff value) in the implemen-
tation of GeneSpring GX software (Agilent, Palo Alto, CA). The presented real-time RT-PCR data support the microarray-
based findings except when marked by '$' sign (microarrays suggested CARP-3 expression > CARP12 expression, while RT-
PCR showed CAR-P3 expression = CAR-P12 expression) and '&' sign (in contrast to microarrays, no inter-group differences 
were detected by RT-PCR).Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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differences were either absent or were significantly less
pronounced in CAR-P12 animals. Furthermore, in con-
trast to the baseline conditions, the adult inflammation-
induced changes in multiple members of several large
gene groups in our arrays. In particular, eight of the
affected genes encode interleukins (IL-1α, IL-5, IL-6, IL-
12A, IL-15, IL-20, IL-24) and the interleukin receptor, IL-
12 β1, which are pro-inflammatory molecules [35-39].
Another eight genes encode glutamate neurotransmis-
sion-related proteins, including metabotropic mGluR1a
receptor, subunits of NMDA receptor (NR1-4a, NR1-1b,
NR2A, NR2D, NR1-4a) and AMPA glutamate (GluRD and
GluR6) receptors, which play mostly pro-nociceptive roles
in the LDH [13,40]. The up-regulated subunits of NMDA
and AMPA receptors are known to have multiple roles in
modulating functionality of these receptors, nevertheless,
the overall effect of their up-regulation is likely to increase
NMDA and AMPA receptor ligand sensitivity and intracel-
lular signaling [41-46]. The next group of eight genes
encodes eight 5-HT serotonergic receptors (5-HT1a, 5-
HT1d, 5-HT1e, 5-HT1f, 5-HT2c, 5-HT4, 5-HT5a, and 5-
HT6). Unfortunately, the specific outcome of the
observed up-regulation of these receptors is difficult to
predict, since the actions of most of these receptors have
not been tested in spinal cord neurons, and those recep-
tors that have been examined are capable of exerting both
pro- and anti-nociceptive actions depending on their cel-
lular position within the spinal dorsal horn [13]. Finally,
a group of six genes encodes either subunits of the GABAA
receptor (GABAAα2, GABAAα4, GABAAα5, and GABAAα6
– all subunits enhancing activity of GABAA ionic channels;
[47]) or GABAB receptors (GABAB1b and GABAB1c). As
mentioned earlier, these receptors inhibit neuronal facili-
tation in the spinal dorsal horn [12-14]. The remaining
genes code for CGRP, CGRPR receptor, and CALK-2,
which have been suggested to have a pro-nociceptive
influence in the LDH [13], and neurotrophin-3, and TrkA
and TrkC neurotrophin receptors, which reportedly par-
ticipate in the neurotrophin-associated maintenance of
the central spinal sensitization associated with persistent
pain [48-53]. Based on the aforementioned observations,
it is reasonable to assume that the abnormal regulation of
expression of numerous genes involved in processing
nociceptive information in the LDH ipsilateral to the neo-
natally CAR-injected hindpaw may play a significant role
in the enhanced hyperalgesia during inflammation of this
paw in adult rats.
Among the examined genes, only one (encoding NK2
receptor) showed stronger adult inflammation-induced
expression in animals subjected to neonatal CAR injection
outside of the sensitive period as compare to those
receiving CAR within this period. Activation of NK2 is
known to promote analgesia [54].
Finally, it is interesting that very few genes expressing sig-
nificant inter-group differences in their levels prior to
inflammation showed such differences after inflamma-
tion was re-introduced in adult animals. Only GABAB1b
and σ receptors continued to display significant up-regu-
lation upon adult inflammation of the neonatally-injured
paw in the LDH of CAR-P3 rats in the ipsilateral and bilat-
eral manner respectively. Unfortunately, the microarray
analysis as performed in this study, does not allow us to
discern the reasons why the majority of genes displaying
baseline CAR-P3-specific changes failed to show altera-
tions during adult inflammation.
Real-time RT-PCR-determined levels of expression (calcu- lated as R0 using β-actin as internal control) for genes identi- fied by having significantly altered basal levels in the left LDH  ipsilateral to the neonatally-injured hindpaw in CAR-P3 as  compared to their expressions in the corresponding LDH of  CONT and CAR-P12 animals (Table 2) Figure 2
Real-time RT-PCR-determined levels of expression (calcu-
lated as R0 using β-actin as internal control) for genes identi-
fied by having significantly altered basal levels in the left LDH 
ipsilateral to the neonatally-injured hindpaw in CAR-P3 as 
compared to their expressions in the corresponding LDH of 
CONT and CAR-P12 animals (Table 2). The data for the 
LDH ipsilareal to the neonatally-injured paw and the LDH 
contralateral to that paw are shown separately. Each data-
point represents a mean of 5 animals in a group. The data 
were analyzed using one-way ANOVAs, (with the Benjamini 
and Hochberg's FDR correction procedure set at the P-value 
cutoff of 0.05) followed by Tukey's post-hoc tests (with the 
same P-cutoff value) in the implementation of GeneSpring 
GX software (Agilent, Palo Alto, CA). The presented real-
time RT-PCR data support the microarray-based findings.Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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Real-time RT-PCR-determined levels of expression (calculated as R0 using β-actin as internal control) for genes identified by  microarray profiling as showing significant adult inflammation-induced alterations in their expressions in the left LDH (ipsilat- eral to the CFA-inflammed neonatally-injured hindpaw) in CAR-P3 rats as compared to those in the left LDH of CONT and  CAR-P12 animals after inflammation of the corresponding paw (Table 3) Figure 3
Real-time RT-PCR-determined levels of expression (calculated as R0 using β-actin as internal control) for genes identified by 
microarray profiling as showing significant adult inflammation-induced alterations in their expressions in the left LDH (ipsilat-
eral to the CFA-inflammed neonatally-injured hindpaw) in CAR-P3 rats as compared to those in the left LDH of CONT and 
CAR-P12 animals after inflammation of the corresponding paw (Table 3). A, genes, which were identified by microarrays as 
having similar expressions in CONT and CARP-12 groups, but changed (up-regulated) in CAR-P3 group. B, genes, which were 
identified by microarrays as having differences in expression between CONT and CAR-P3 and CAR-P12 groups as well as 
between CARP-3 and CAR-P12 groups (both when CAR-P3 > CAR-P12 and CAR-P3 < CAR-P12). Each data-point represents 
a mean of 5 animals in a group. The data were analyzed using one-way ANOVAs, (with the Benjamini and Hochberg's FDR cor-
rection procedure set at the P-value cutoff of 0.05) followed by Tukey's post-hoc tests (with the same P-cutoff value) in the 
implementation of GeneSpring GX software (Agilent, Palo Alto, CA). The presented real-time RT-PCR data support the 
microarray-based findings except when marked by '$' sign (microarrays suggested CARP-3 expression > CARP12 expression, 
while RT-PCR showed CAR-P3 expression = CAR-P12 expression).Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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The limited screening of gene expressions described in
this paper is just the first step toward understanding the
molecular mechanisms involved in long-term alteration
in nociception produced by early local noxious insult.
Both much wider high throughput profiling studies,
including those of proteins, and more focused and
detailed investigations, addressing the sites of molecular,
alterations on the cellular level and experimental testing
of their functional consequences, are needed to fully
address this question.
Methods
Animals
Adult female and male Sprague-Dawley breeders were
purchased from Harlan (Indianapolis, IN) and bred at the
University of Maryland Animal Facility. Litters with ≥10
pups were selected for this study. They were divided into
three groups. In the CAR-P3 and CAR-P12 groups, the
pups received a single injection of 0.25% CAR in sterile
0.9% saline (1 µl/g) in to the plantar surface of their left
hindpaw at 9:00 pm on either P3 or P12 respectively. The
injection was conducted with a microliter syringe with a
31-gauge needle. Previously, we demonstrated that, at
both ages, such an injection induces short-lasting (~48 h)
increase in the diameter of the injected paw, accompanied
by reduced withdrawal latencies to thermal and mechani-
cal noxious stimulation [8]. Pups in the CONT group
received no injections. Except for the hindpaw injection
procedure, all rats were subject to the same human inter-
vention involved in routine animal care such as weekly
cage cleaning and daily food and water changes, etc. We
did not include a brief handling control group since brief
handling after birth has been shown not to produce long-
term alterations in pain responsivity [8]. A saline-injected
control group also was not included since saline injection
by itself is a noxious experience and it is beyond the scope
of the present study to distinguish between long-term
consequences of different types of early noxious insults.
After weaning at P21, male pups were housed in groups of
three with animals in any given cage receiving the same
neonatal treatment. The females were used in different
experiments (we understand the importance of extending
the present studies to females, which will be done in the
future). At P59, the left hindpaws of half of the rats in
CONT, CAR-P3 and CAR-P12 groups received an inflam-
mation-inducing injection of CFA (0.05 ml, 1:1 oil/saline
emulsion). The rest of the animals received no injections.
Twenty-four hours later (at P60), all rats were anesthe-
tized by i.p. injections of Nembutal. The left and right
LDH of the L4, L5 levels were dissected out and snap-fro-
zen in liquid nitrogen. All experiments were approved by
the University Institutional Animal Care and Use
Committee.
Microarrays
In this part of the study, we used left and right sides of the
LDH from ten CAR-P3, ten CAR-12, and ten CONT
animals, one half at baseline and another half after CFA-
induced inflammation of the neonatally-injured paw per
group. For both baseline and inflammation states, each
animal belonged to a different litter. For each state, the
collected samples were processed in randomly selected
CAR-P3/CONT and CAR-P12/CONT pairs per microarray
slide [5 pairs each; 10 pairs for both comparison groups ×
2 (left and right) = 20 microarray slides total/inflamma-
tion state].
For the analysis, the total sample RNA was isolated with
TRIzol protocol (Invitrogen, Carsbad, CA). The RNA yield
was determined using a DU 640 Spectrophotometer
(Beckman, Coulter, Fullerton, CA). The 260/280 nm
ratios of the samples were 1.8. The RNA isolated from a
specific pairs of samples (5 µg RNA per sample) was
reverse transcribed utilizing a 3DNA Array Detection Kit
(Genesphere, Hartfield, PA); with primers containing dif-
ferent capture sequences for CONT and experimental
(CAR-P3 and CARP-12] tissue. The resultant cDNA was
then hybridized to oligonucleotide microarrays custom
designed and printed for us by TeleChem International
(Sunnyvale, CA). The sequences of the chosen mRNAs
were obtained from the Gene Bank http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi with their
unique regions identified with the help of the 'BLAST-2
Sequences' and 'Multiple Alignment' websites (http://
www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi and
http://www.genebee.msu.su/services/
malign_reduced.html respectively). The same two web-
sites were used for the verification of the uniqueness of the
oligoprobe sequences selected by TeleChem Interna-
tional. Probes for four internal standards, glyceradehyde-
3-phosphate-dehydrogenase (GAPDH), β-actin, ubiqui-
tin, and βIII-tubulin, were also included in the microar-
rays. The oligonicleotide probes were printed with the
TeleChem's advanced Stealth technology on SuperAlde-
hyde substrate coated-glass slides in quadruplicates, with
each of the four sets of probes occupying a different quad-
rant of the slide microarray matrix. The cDNA hybridiza-
tion was performed at 55°C for 16 h in 2 × SDS-Based
Hybridization Buffer (3DNA Array Detection Kit, Gene-
sphere, Hartfield, PA). The hybridization was followed by
washing with 2 × SSC and 0.2% SDS at 42°C, 2 × SSC at
room temperature, and 0.2 × SSC at room temperature, 10
min each. Washed slides were air-dried for 30 sec. For flu-
orescent labeling of microarray-bound cDNA, the slides
were incubated for 3 h at 65°C with a Capture Reagent
Hybridization Mixture from a 3DNA Array Detection Kit
(Genesphere Inc, Hatfield, PA). In this mixture, Alexa 546
fluorochrome-incorporating dendrimers contained sin-
gle-stranded arms complimentary to the 'capture'Molecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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sequences used in the reverse transcription of RNA from
CONT samples, while Alexa 647 fluorochrome-incorpo-
rating dendrimers contained arms complimentary to the
capture sequences used in reverse transcription of RNA
from CAR-P3 and CARP-12 samples. The labeling reaction
was terminated by washing the microarray slides at room
temperature for 10 min with 0.005% Triton in 2 × SSC
and for another 10 min in 0.2 × SSC. After that, the slides
were air-dried for 30 sec. The processed microarray slides
were scanned on a GenePix 4100A scanner (Axon Instru-
ment, Union City, CA) with the laser excitation at 532 nm
[emission filter 575DF35 (green); photomultiplier volt-
age 550] for Alexa 546 (control samples) and the laser
excitation at 635 nm [emission filter 670DF40 (red); pho-
tomultiplier voltage 695] for Alexa 647 (experimental
samples). The densitometry was performed with GenePix
Pro 4.1 (Axon Instruments, Union City, CA). Background
was subtracted using the 'Local Background Correction'
procedure and quality control was achieved by 'Quality
Control' feature of the GenePix software. Since our micro-
array slides generated four spots per gene, the median
intensity of these quadruplicates was calculated. For each
array, the data were normalized with Acuity 3.1 (Axon
Instruments, Union City, CA) by applying locally
weighted scatterplot smoothing (LOWESS) transforma-
tion that utilizes all genes in the microarray [55] and by
the internal standards, GAPDH, beta-actin, ubiquitin and
βIII-tubulin [56]. LOWESS normalization eliminated
non-linear die distortion of the microarray data [55]. The
statistical analysis was conducted separately for each
inflammation state of the adult animals and the left and
right sides as described in [28]. For this analysis, the data
from the CONT samples were adjusted to produce a uni-
form value of 1. Then, the levels of the gene expressions
between CAR-P3, CAR-P12, and CONT groups were com-
pared employing one-way ANOVAs (with the false discov-
ery rate (FDR) multiple testing error correction procedure
of Benjamini and Hochberg [57] set at the P-value cutoff
of 0.05) followed by Tukey's post-hoc tests (with the same
P-cutoff value) in the implementation of GeneSpring GX
software (Agilent, Palo Alto, CA).
Real-Time RT-PCR
For the verification of the changes in gene expression sug-
gested by the microarray analysis, real-time RT-PCR was
conducted in 5 samples per relevant group, each obtained
from an animal belonging to a different litter. Also, none
of these litters were used in the above-described microar-
ray analysis. All the baseline changes were re-examined
bilaterally. The changes induced by CFA-based inflamma-
tion were re-examined only ipsilaterally. β-actin was
employed as the endogenous control [28]. For each assay,
the total RNA was isolated as described for microarray
analysis, and then treated with Amplification Grade Deox-
yribonuclease I (1 u/µg RNA; Invitrogen, Carlsbad, CA)
for 15 min at 25°C. Reverse transcription was performed
using Omniscript RT kit (Qiagen, Vanencia, CA) using
random hexamers as primers. Real-time PCR utilized
TaqMan assay, which requires two primers and a fluores-
cence-labeled probe for cDNA amplification and visuali-
zation. All TaqMan PCR primers and probes were
designed using Primer Express 1.5a (Applied Biosystems,
Foster City, CA) and custom-synthesized by Applied Bio-
systems (Foster City, CA). The PCR reactions were carried
out on an ABI Prism 7000 Sequence Detector (Applied
Biosystems, Foster City, CA). All PCR reactions were run
in a monoplex mode – amplification of one gene per reac-
tion well in a PCR plate. Each reaction included sample
cDNA (1 µl), the reverse primers (100–500 nM each) and
probes (50–100 nM) for the gene of interest, TaqMan
Universal Master Mix (25 µl, Applied Biosystems) and
deionized water that brought the total volume to 50 µl.
The cycles were run at 95°C/10 min, 95°C/15 sec × 45,
and 60°C/1 min. All assays were performed in triplicates.
The normalization to internal standards and expression of
the resultant data was calculated using amplification plot
method of Pierson et al. [58] implemented in DART-PCR
Excel workbook http://www.gene-quantification.info/
bestkeeper.html. In this method amplification efficiency
for both target and control genes were calculated from raw
data around the midpoint of the transformed signal
range, which is more accurate than when derived from an
external standard curve [59]. The average efficiency from
all (experimental and control) runs of a given gene was
then calculated (since this improves accuracy as compared
to the use of individual run efficiencies; [58]). The
obtained efficiency is used in generating Starting Fluores-
cence Value for a given gene in a sample (R0), which is
proportional to the starting template quantity. Finally, R0
for the target gene is normalized to R0 of the internal con-
trol from the same sample [R0(sample) = R0(target)/R0(control)].
To allow inter-plate comparison, the R0(sample) is further
normalized to R0(standard) generated for the same target
gene and internal control in the wells with the "standard"
cDNA run on the same plate with the experimental sam-
ples [R0(sample 2 × normalized) = R0(sample)/R0(standard)]. The
'standard' cDNA for the entire study was generated from a
'standard tissue homogenate' that was pooled from the
LDH tissue of 10 rats dedicated for this purpose. To assess
possible contamination with chromosomal DNA, several
RNA samples were processed for PCR with β-actin probe
and primers without the RT step. No amplification prod-
ucts were detected.
The statistical analyses of samples from the left and right
sides and from different inflammation states of adult ani-
mals were performed separately. These analyses include
one-way ANOVAs (with the Benjamini and Hochberg's
FDR correction procedure set at the P-value cutoff of 0.05)
followed by Tukey's post-hoc tests (with the same P-cutoffMolecular Pain 2005, 1:27 http://www.molecularpain.com/content/1/1/27
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value) in the implementation of GeneSpring GX software
(Agilent, Palo Alto, CA).
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